Eli Lilly examined for clinical trials in Xinjiang and military locations in China
Investigation Launched into Eli Lilly’s Operations in China John Moolenaar, the chairman of the Chinese Communist Party’s House Select Committee, has initiated an inquiry into Eli Lilly’s clinical trial practices in China. The committee is focusing on research conducted at hospitals linked to the Chinese military, particularly in Xinjiang. In a letter obtained recently, Moolenaar’s […]